Nitric oxide and the cyclooxygenase pathway.
Salvemini
D
D
G.D. Searle, Monsanto Company, St Louis, MO 63167, USA.
Seibert
K
K
Masferrer
J L
JL
Settle
S L
SL
Misko
T P
TP
Currie
M G
MG
Needleman
P
P
D000594:Amino Acid Oxidoreductases / Q000096:biosynthesis*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D015232:Dinoprostone / Q000378:metabolism; D004790:Enzyme Induction; D004926:Escherichia coli; D006146:Guanidines / Q000494:pharmacology; D006869:Hydronephrosis / Q000503:physiopathology*; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000503:physiopathology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D019323:omega-N-Methylarginine
D006146:Guanidines; D008070:Lipopolysaccharides; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D011451:Prostaglandin-Endoperoxide Synthases; D000594:Amino Acid Oxidoreductases; D015232:Dinoprostone; D001920:Bradykinin; C004479:pimagedine; D007213:Indomethacin